hTERT启动子驱动的HSV-TK基因治疗胰腺癌的实验研究的开题报告

精品文档---下载后可任意编辑hTERT 启动子驱动的 HSV-TK 基因治疗胰腺癌的实验讨论的开题报告摘 要胰腺癌是一种高度侵袭性的恶性肿瘤，在临床上难以完全治愈。目前，传统治疗方法效果不佳，因此需要寻找新的治疗手段。基因治疗是胰腺癌治疗的热门讨论方向之一。本讨论旨在探讨利用 hTERT 启动子驱动的 HSV-TK 基因治疗胰腺癌的可行性和安全性。本讨论中，我们将使用胰腺癌细胞株和小鼠模型，验证 hTERT 启动子驱动的HSV-TK 的治疗效果。我们将设计试验组和对比组，在不同时间点和剂量下给予治疗，观察治疗的影响和不良反应。实验最终目标是验证该治疗方法的有效性和安全性。关键词：胰腺癌；基因治疗；hTERT 启动子；HSV-TK；小鼠模型AbstractPancreatic cancer is a highly invasive malignancy that is difficult to cure clinically. Currently, traditional methods of treatment are not effective, therefore, new treatment methods need to be explored. Gene therapy is one of the hot research topics in pancreatic cancer treatment. This study aims to explore the feasibility and safety of using hTERT promoter-driven HSV-TK gene therapy to treat pancreatic cancer.In this study, we will use pancreatic cancer cell lines and mouse models to verify the therapeutic effect of hTERT promoter-driven HSV-TK. We will design the experimental group and control group, provide treatment at different time points and doses, observe the effects of treatment and adverse reactions. The ultimate goal of the experiment is to verify the effectiveness and safety of the treatment method.Keywords: pancreatic cancer; gene therapy; hTERT promoter; HSV-TK; mouse model.